The role of the determination of the CD20 antigen through quantitative flow cytometry in complex cases of rheumatoid arthritis treated with anti-TNF-alpha.
Hobi
A
A
Department of Rheumatology, Cantonal Hospital Fribourg, 1708 Fribourg, Switzerland.
Bihl
T
T
Fellay
B
B
Waldburger
M
M
D000368:Aged; D018951:Antigens, CD20 / Q000032:analysis*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D001402:B-Lymphocytes / Q000276:immunology*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D008297:Male; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018951:Antigens, CD20; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha